Novozymes has underestimated fluctuating bioenergy industry

Growth in Novozymes' bioenergy division has fluctuated greatly. As such, CFO Prisca Havranek-Kosicek will not specify the size of bioethanol's part in the company's new strategy, annual organic growth of 5 percent up until 2022. Novozymes is watching developments in China with interest, however, where new admixture regulations will enter force during 2020.

Log in to read our articles

Welcome to EnergyWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles

Latest News


See all

See all